Inactive Instrument

News Plasmatech Biopharmaceuticals Inc Nasdaq

Stocks

US72754H1095

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

06-29	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Value-Defensive Index	CI

All News

Mentions Relevance

07-01	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
06-29	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Value-Defensive Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Defensive Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Microcap Growth Benchmark Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 2500 Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 2000 Growth Benchmark	CI
06-12	Abeona Therapeutics Inc. Announces Resignation of Michael Amoroso as Member of Board of Directors, Nominating and Corporate Governance Committee, Effective June 11, 2026	CI
06-04	Abeona Therapeutics Inc Participates in Pre-Investigational New Drug Meeting with Fda Regarding Abo-701	CI
06-01	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
05-26	Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences	AQ
05-13	Abeona Therapeutics Inc., Q1 2026 Earnings Call, May 13, 2026
05-13	Abeona Therapeutics : Presentation Q1 2026 PDF Q1 2026	PU
05-13	Abeona Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	Abeona Therapeutics: Q1 Earnings Snapshot	AQ
05-13	Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update	AQ
05-11	Abeona Therapeutics Inc Activates Children's Hospital of Philadelphia as New Qualified Treatment Center for Zevaskyn	CI
05-11	Abeona Therapeutics announces activation of Children's Hospital of Philadelphia as a new qualified treatment center for Zevaskyn	RE
05-11	Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®	AQ
05-04	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
05-04	Abeona Therapeutics® Announces Date of First Quarter Financial Results	AQ
05-01	Abeona Therapeutics : reg; Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PU
04-07	Abeona Therapeutics Inc. Appoints Keith A. Goldan as A New Independent Member to Its Board of Directors as Chairman of Audit Committee , Effective as of April 1, 2026	CI